Your browser doesn't support javascript.
loading
Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway.
Wang, Yan-Hang; Lv, Hai-Ning; Cui, Qing-Hua; Tu, Peng-Fei; Jiang, Yong; Zeng, Ke-Wu.
Afiliación
  • Wang YH; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Lv HN; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Cui QH; School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  • Tu PF; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Jiang Y; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. yongjiang@bjmu.edu.cn.
  • Zeng KW; State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China. ZKW@bjmu.edu.cn.
Acta Pharmacol Sin ; 41(2): 173-180, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31506572
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microglía / Inflamasomas / Inflamación Tipo de estudio: Risk_factors_studies Idioma: En Revista: Acta Pharmacol Sin Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microglía / Inflamasomas / Inflamación Tipo de estudio: Risk_factors_studies Idioma: En Revista: Acta Pharmacol Sin Año: 2020 Tipo del documento: Article País de afiliación: China